The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Miceli James T since 2007.
The trader's CIK number is 1385168.
At the time of the last reporting, Miceli James T was the 10% Owner of Immunosyn Corp. (stock ticker symbol NONE).
Also see all insider trading activities at Immunosyn Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | IMYN | 573,137 | $41,010 | 0 | $0 | 0 | $0 |
| 2007 | IMYN | 125,000 | $0 | 805,287 | $4,194,742 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-07-27 | IMYN | Buy | 50,000 | .07 | 3,500 |
| 2009-07-13 | IMYN | Buy | 10,000 | .08 | 800 |
| 2009-08-31 | IMYN | Buy | 100,000 | .05 | 5,000 |
| 2009-07-08 | IMYN | Buy | 36,500 | .09 | 3,102 |
| 2009-07-10 | IMYN | Buy | 10,000 | .09 | 900 |
| 2009-07-07 | IMYN | Buy | 10,000 | .07 | 700 |
| 2009-07-06 | IMYN | Buy | 2,857 | .06 | 171 |
| 2009-08-26 | IMYN | Buy | 77,000 | .06 | 4,620 |
| 2009-07-28 | IMYN | Buy | 50,000 | .07 | 3,500 |
| 2009-07-14 | IMYN | Buy | 50,000 | .09 | 4,600 |
| 2009-07-15 | IMYN | Buy | 61,500 | .09 | 5,658 |
| 2009-07-20 | IMYN | Buy | 12,780 | .08 | 1,022 |
| 2009-06-30 | IMYN | Buy | 50,000 | .07 | 3,500 |
| 2009-07-22 | IMYN | Buy | 52,500 | .07 | 3,937 |
| 2007-11-01 | IMYN | Sale | 5,333 | 7.50 | 39,997 |
| 2007-10-24 | IMYN | Sale | 8,000 | 5.00 | 40,000 |
| 2007-10-18 | IMYN | Sale | 193,783 | 6.88 | 1,332,258 |
| 2007-10-03 | IMYN | Sale | 367,069 | 4.51 | 1,655,848 |
| 2007-06-12 | IMYN | Sale | 38,632 | 5.00 | 193,160 |
| 2007-08-24 | IMYN | Buy | 125,000 | .00 | 0 |
| 2007-08-23 | IMYN | Sale | 192,470 | 4.85 | 933,479 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Miceli James T (10% Owner of Immunosyn Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.